• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Cytomegalic Inclusion Disease

Cytomegalic Inclusion Disease - 21 Studies Found

Completed : Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
: Cytomegalovirus Infection
: 2008-08-05
: Drug: Single arm (ganciclovir and valganciclovir) Patients received a short induction of IV ganciclovir
Terminated : Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant
: Cytomegalovirus Infections
: 2005-10-17
:
  • Drug: Valganciclovir
  • Drug: Ganciclovir

Completed : Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy
: Cytomegalovirus Infections
: 2015-10-23
: Other: Blood draw and MRI The study is observational. The treatment-plan of the underlying disease remai
Completed : Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
: Cytomegalovirus Infections
: 2016-01-26
:
  • Drug: Drug conversion to sirolimus

Completed : Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
:
  • Cytomegalovirus Infection
  • Preterm Infants

: 2010-07-26
: Procedure: ultrashort heat inactivation
Completed : CMV-CTL for the Treatment of CMV Infection After HSCT
:
  • Cytomegalovirus Infections
  • Hematological Disease

: 2016-12-18
:
  • Biological: CMV-CTL donor deri

Completed : A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
:
  • Cytomegalovirus Infections
  • HIV Infections

: 1999-11-02
: Drug: Ganciclovir
Completed : IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
: Cytomegalovirus Infections
: 2006-02-21
:
  • Drug: Valganciclovir 900 mg or

Recruiting : Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
:
  • Transplantation Infection
  • Cytomegalovirus Infection

: 2014-09-01
:
  • Drug: Everolimus

Terminated : Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study
: CMV Infection
: 2016-03-23
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.